1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The investigators evaluated the effect of pre-biopsy treatment with 1-deamino-8-D-arginine
(DDAVP) on the incidence of post-biopsy bleeding complications. This is a IV phase single
centre, double blind, randomized controlled study in patients, with acute and chronic
nephropathy, undergoing ultrasound-guided percutaneous renal biopsy.